Literature DB >> 15878287

The use of correlation integrals in the study of localized muscle fatigue of elbow flexors during maximal efforts.

Antonis P Stylianou1, Carl W Luchies, David E Lerner, Gregory W King.   

Abstract

Innovative applications of non-linear time series analysis have recently been used to investigate physiological phenomena. In this study, we investigated the feasibility of using the correlation integral to monitor the localized muscle fatigue process in the biceps brachii during sustained maximal efforts. The subjects performed isometric maximum contractions until failure in elbow flexion (90 degrees from neutral). The median and the 70th percentile frequency of the Surface electromyography (SEMG) power spectrum, the integrated SEMG, and the Correlation Integral (CI) were evaluated during the trials. The linear correlation between these variables and the elbow torque production was used to quantify the ability of a parameter to follow the fatiguing process. The CI had the highest linear correlation with torque (0.77 (0.12SD)), while the spectral indices correlations with torque were much lower. The decreasing trend of the torque production was followed by the spectral indices for only the beginning part of the contraction, while the CI increased sharply after the torque production fell to about 0.60 of the MVC. This suggests that the CI is sensitive to different changes of the SEMG signal during fatigue than the spectral variables.

Entities:  

Mesh:

Year:  2005        PMID: 15878287     DOI: 10.1016/j.jelekin.2005.02.004

Source DB:  PubMed          Journal:  J Electromyogr Kinesiol        ISSN: 1050-6411            Impact factor:   2.368


  1 in total

1.  Muscle modifications in fibromyalgic patients revealed by surface electromyography (SEMG) analysis.

Authors:  Laura Bazzichi; Marco Dini; Alessandra Rossi; Silvia Corbianco; Francesca De Feo; Camillo Giacomelli; Cristina Zirafa; Claudia Ferrari; Bruno Rossi; Stefano Bombardieri
Journal:  BMC Musculoskelet Disord       Date:  2009-04-15       Impact factor: 2.362

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.